June 21, 2016
12:00 - 2:00 p.m. ET
Center for Strategic and International Studies (CSIS) building
1616 Rhode Island Ave. NW
Washington, DC 20036
Envisioning Value in Personalized Medicine, featuring Rick Chapman, Ph.D., M.S., Director of Health Economics, ICER with representatives from the Global Liver Institute, NPC and PhRMA
PMC members click here to register: http://pmc.site-ym.com/events/register.aspx?id=821373
Rick Chapman, Ph.D., M.S., Director of Health Economics, Institute for Clinical and Economic Review (ICER), will join Donna R. Cryer, J.D., President & CEO, Global Liver Institute; Dan Leonard, President, National Pharmaceutical Council (NPC); and Randy Burkholder, Vice President, Policy and Research, Pharmaceutical Research and Manufacturers of America (PhRMA), for a discussion on personalized medicine technology value assessment. The conversation will help inform PMC's future engagement with ICER.